Several pharmaceutical companies manufacture injection pens, which are devices designed for the convenient and accurate administration of injectable medications. These pens are commonly used for self-administration of various medications, including insulin for diabetes, growth hormones, and certain types of therapies.
Eli Lilly's launch of Trulicity Pen This glucagon-like peptide-1 (GLP-1) receptor agonist pen for diabetes management offers a pre-filled, single-dose option, simplifying use and potentially improving adherence.
Novo Nordisk's Xultoty pen advancements This company received FDA approval for a higher-dose Xultoty pen for adults with type 2 diabetes, combining insulin and GLP-1 therapy in a single pen for increased convenience.
Sanofi's Soliqua Flexpen approval This pre-mixed insulin and GLP-1 pen for type 2 diabetes management, with flexible dosing options, caters to individual patient needs and potentially improves treatment outcomes.
Owen Mumford's focus on smart pens This company continues to develop and refine its smart pen technologies, with features like blood glucose monitoring and real-time data communication, aiming to provide a more holistic diabetes management system.
List of Injection Pen Key companies in the market:
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)